Figure 2. Antigenic characterization of potential HBoV epitopes P1 and P2.
(A) Titers of IgG antibody against P1 and P2 in mouse sera. The titers of mice sera were determined as a series of two-fold dilutions by ELISA. (B) The immunological cross-reactivity was analyzed between mice antisera against P1 or P2 with virus-like particles (VLPs) of HBoV1, 2, 3, and 4 by Western blot. The VLPs of human parvovirus B19 and PARV4 were used as controls.